Divis Laboratories' third quarter profit is seen rising 26 percent year-on-year to Rs 277.93 crore and revenue may increase 20.2 percent to Rs 947.6 crore, according to average of estimates of analysts polled by CNBC-TV18.
Operating profit in Q3 is likely to jump 28.2 percent to Rs 364 crore and margin may expand 240 basis points to 38.4 percent compared to year-ago period.
Revenue growth may be led by increased capacity utilisation at new DSN SEZ units. DSN SEZ capacity utilisation is likely to go upto 80 percent during the quarter against 75 percent in corresponding quarter of last fiscal due to favourable mix.
In Q2FY16, DSN SEZ contribution was Rs 195 crore against Rs 232 crore in preceding quarter and Rs 817 crore in FY15.
Overall growth may be driven largely by generics business.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
